Literature DB >> 19347622

High-content screening: flow cytometry analysis.

Bruce S Edwards1, Susan M Young, Irena Ivnitsky-Steele, Richard D Ye, Eric R Prossnitz, Larry A Sklar.   

Abstract

The HyperCyt high-throughput (HT) flow cytometry sampling platform uses a peristaltic pump, in combination with an autosampler, and a novel approach to data collection, to circumvent time-delay bottlenecks of conventional flow cytometry. This approach also dramatically reduces the amount of sample aspirated for each analysis, typically requiring ~2 microL per sample while making quantitative fluorescence measurements of 40 or more samples per minute with thousands to tens of thousands of cells in each sample. Here, we describe a simple robust screening assay that exploits the high-content measurement capabilities of the flow cytometer to simicroltaneously probe the binding of test compounds to two different receptors in a common assay volume, a duplex assay format. The ability of the flow cytometer to distinguish cell-bound from free fluorophore is also exploited to eliminate wash steps during assay setup. HT flow cytometry with this assay has allowed efficient screening of tens of thousands of small molecules from the NIH Small-Molecule Repository to identify selective ligands for two related G-protein-coupled receptors, the formylpeptide receptor and formylpeptide receptor-like 1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19347622      PMCID: PMC4476789          DOI: 10.1007/978-1-60327-545-3_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  High throughput flow cytometry.

Authors:  F W Kuckuck; B S Edwards; L A Sklar
Journal:  Cytometry       Date:  2001-05-01

2.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

3.  High-throughput screening with HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands.

Authors:  Susan M Young; Cristian Bologa; Eric R Prossnitz; Tudor I Oprea; Larry A Sklar; Bruce S Edwards
Journal:  J Biomol Screen       Date:  2005-06

4.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1.

Authors:  Y Le; H Yazawa; W Gong; Z Yu; V J Ferrans; P M Murphy; J M Wang
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

6.  High-throughput flow cytometry: validation in microvolume bioassays.

Authors:  Sergio Ramirez; Charity T Aiken; Brett Andrzejewski; Larry A Sklar; Bruce S Edwards
Journal:  Cytometry A       Date:  2003-05       Impact factor: 4.355

7.  Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform.

Authors:  Bruce S Edwards; Susan M Young; Tudor I Oprea; Cristian G Bologa; Eric R Prossnitz; Larry A Sklar
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

8.  Differential activation of formyl peptide receptor-like 1 by peptide ligands.

Authors:  Yoe-Sik Bae; Hee Jeong Yi; Ha-Young Lee; Eun Jin Jo; Jung Im Kim; Taehoon G Lee; Richard D Ye; Jong-Young Kwak; Sung Ho Ryu
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

9.  Differential activation of formyl peptide receptor signaling by peptide ligands.

Authors:  Yoe-Sik Bae; Ji Young Song; Youndong Kim; Rong He; Richard D Ye; Jong-Young Kwak; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

Review 10.  Properties of the novel proinflammatory supergene "intercrine" cytokine family.

Authors:  J J Oppenheim; C O Zachariae; N Mukaida; K Matsushima
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

View more
  15 in total

1.  Identification of a small molecule yeast TORC1 inhibitor with a multiplex screen based on flow cytometry.

Authors:  Jun Chen; Susan M Young; Chris Allen; Andrew Seeber; Marie-Pierre Péli-Gulli; Nicolas Panchaud; Anna Waller; Oleg Ursu; Tuanli Yao; Jennifer E Golden; J Jacob Strouse; Mark B Carter; Huining Kang; Cristian G Bologa; Terry D Foutz; Bruce S Edwards; Blake R Peterson; Jeffrey Aubé; Margaret Werner-Washburne; Robbie J Loewith; Claudio De Virgilio; Larry A Sklar
Journal:  ACS Chem Biol       Date:  2012-02-01       Impact factor: 5.100

Review 2.  Cell-based assays for high-throughput screening.

Authors:  W Frank An; Nicola Tolliday
Journal:  Mol Biotechnol       Date:  2010-06       Impact factor: 2.695

3.  A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.

Authors:  Chetana M Revankar; Cristian G Bologa; Richard A Pepermans; Geetanjali Sharma; Whitney K Petrie; Sara N Alcon; Angela S Field; Chinnasamy Ramesh; Matthew A Parker; Nikolay P Savchuk; Larry A Sklar; Helen J Hathaway; Jeffrey B Arterburn; Tudor I Oprea; Eric R Prossnitz
Journal:  Cell Chem Biol       Date:  2019-11-06       Impact factor: 8.116

Review 4.  Facts and fiction: cellular models for high throughput screening for HIV-1 reactivating drugs.

Authors:  Vicente Planelles; Frank Wolschendorf; Olaf Kutsch
Journal:  Curr HIV Res       Date:  2011-12-01       Impact factor: 1.581

5.  Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.

Authors:  M Frank Erasmus; Ksenia Matlawska-Wasowska; Ichiko Kinjyo; Avanika Mahajan; Stuart S Winter; Li Xu; Michael Horowitz; Diane S Lidke; Bridget S Wilson
Journal:  Sci Signal       Date:  2016-11-29       Impact factor: 8.192

Review 6.  Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.

Authors:  I A Schepetkin; A I Khlebnikov; M P Giovannoni; L N Kirpotina; A Cilibrizzi; M T Quinn
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

7.  Cluster cytometry for high-capacity bioanalysis.

Authors:  Bruce S Edwards; Jingshu Zhu; Jun Chen; Mark B Carter; David M Thal; John J G Tesmer; Steven W Graves; Larry A Sklar
Journal:  Cytometry A       Date:  2012-03-21       Impact factor: 4.355

8.  The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.

Authors:  Ann R Holmes; Mikhail V Keniya; Irena Ivnitski-Steele; Brian C Monk; Erwin Lamping; Larry A Sklar; Richard D Cannon
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

9.  Fluidics.

Authors:  Pearlson P Austin Suthanthiraraj; Steven W Graves
Journal:  Curr Protoc Cytom       Date:  2013-07

10.  High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45.

Authors:  Stephanie M Stanford; Rekha G Panchal; Logan M Walker; Dennis J Wu; Matthew D Falk; Sayantan Mitra; Sagar S Damle; David Ruble; Teodora Kaltcheva; Sheng Zhang; Zhong-Yin Zhang; Sina Bavari; Amy M Barrios; Nunzio Bottini
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.